sábado, 20 de marzo de 2021

Tocilizumab in patients with severe COVID-19: a retrospective cohort study - The Lancet Rheumatology

Tocilizumab in patients with severe COVID-19: a retrospective cohort study - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario